XML 53 R41.htm IDEA: XBRL DOCUMENT v3.19.1
Fair Value of Financial Instruments (Tables)
3 Months Ended
Mar. 31, 2019
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on a Recurring Basis
The following table presents the Company’s financial instruments measured at fair value on a recurring basis as of March 31, 2019 and December 31, 2018, respectively, on the Company’s condensed consolidated balance sheets (dollar amounts in thousands):
 
Measured at Fair Value on a Recurring Basis at
 
March 31, 2019
 
December 31, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets carried at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment securities available for sale:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency RMBS
$

 
$
1,023,938

 
$

 
$
1,023,938

 
$

 
$
1,037,730

 
$

 
$
1,037,730

Non-Agency RMBS

 
314,086

 

 
314,086

 

 
214,037

 

 
214,037

CMBS

 
245,941

 

 
245,941

 

 
207,785

 
52,700

 
260,485

Multi-family loans held in securitization trusts

 

 
14,328,336

 
14,328,336

 

 

 
11,679,847

 
11,679,847

Distressed and other residential mortgage loans, at fair value

 

 
875,566

 
875,566

 

 

 
737,523

 
737,523

Derivative assets:
 
 
 
 
 
 


 
 
 
 
 
 
 


Interest rate swaps (1)

 
14,873

 

 
14,873

 

 
10,263

 

 
10,263

Investments in unconsolidated entities

 

 
36,575

 
36,575

 

 

 
32,994

 
32,994

Total
$

 
$
1,598,838

 
$
15,240,477

 
$
16,839,315

 
$

 
$
1,469,815

 
$
12,503,064

 
$
13,972,879

Liabilities carried at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Multi-family collateralized debt obligations
$

 
$

 
$
13,547,195

 
$
13,547,195

 
$

 
$

 
$
11,022,248

 
$
11,022,248

Total
$

 
$

 
$
13,547,195

 
$
13,547,195

 
$

 
$

 
$
11,022,248

 
$
11,022,248


    
(1) 
All of the Company's interest rate swaps outstanding are cleared through a central clearing house. The Company exchanges variation margin for swaps based upon daily changes in fair value. Includes derivative liabilities of $12.8 million netted against a variation margin of $27.7 million at March 31, 2019. Includes derivative assets of $1.8 million and variation margin of $8.5 million at December 31, 2018.
Changes in Valuation of Level 3 Assets

    
(1) 
All of the Company's interest rate swaps outstanding are cleared through a central clearing house. The Company exchanges variation margin for swaps based upon daily changes in fair value. Includes derivative liabilities of $12.8 million netted against a variation margin of $27.7 million at March 31, 2019. Includes derivative assets of $1.8 million and variation margin of $8.5 million at December 31, 2018.
The following tables detail changes in valuation for the Level 3 assets for the three months ended March 31, 2019 and 2018, respectively (amounts in thousands):

Level 3 Assets:
 
Three Months Ended March 31, 2019
 
Multi-family loans held in securitization trusts
Distressed and other residential mortgage loans
Investments in unconsolidated entities
CMBS held in securitization trusts
 
Total
Balance at beginning of period
$
11,679,847

$
737,523

$
32,994

$
52,700

 
$
12,503,064

Total (losses)/gains (realized/unrealized)
 
 
 
 
 
 
Included in earnings
259,764

9,945

3,892

17,734

 
291,335

Included in other comprehensive income (loss)



(13,665
)
 
(13,665
)
Transfers in




 

Transfers out

(182
)


 
(182
)
Contributions




 

Paydowns/Distributions
(37,485
)
(24,930
)
(311
)

 
(62,726
)
Sales

(6,448
)

(56,769
)
 
(63,217
)
Purchases (1)
2,426,210

159,658



 
2,585,868

Balance at the end of period
$
14,328,336

$
875,566

$
36,575

$

 
$
15,240,477


(1) 
During the three months ended March 31, 2019, the Company purchased PO securities and certain IOs and mezzanine CMBS securities issued from securitizations that it determined to consolidate and included in the Consolidated K-Series. As a result, the Company consolidated assets of these securitizations in the amount of $2.4 billion during the three months ended March 31, 2019 (see Notes 2 and 6)
Changes in Valuation of Level 3 Liabilities
 
Three Months Ended March 31, 2018
 
Multi-family loans held in securitization trusts
Distressed and other residential mortgage loans
Investments in unconsolidated entities
CMBS held in securitization trusts
 
Total
Balance at beginning of period
$
9,657,421

$
87,153

$
42,823

$
47,922

 
$
9,835,319

Total (losses)/gains (realized/unrealized)
 
 
 
 
 
 
Included in earnings
(184,678
)
(181
)
1,319

939

 
(182,601
)
Included in other comprehensive income (loss)



(4
)
 
(4
)
Transfers in




 

Transfers out




 

Contributions




 

Paydowns/Distributions
(34,434
)
(3,458
)
(638
)

 
(38,530
)
Sales




 

Purchases

15,966



 
15,966

Balance at the end of period
$
9,438,309

$
99,480

$
43,504

$
48,857

 
$
9,630,150


The following table details changes in valuation for the Level 3 liabilities (Multi-family CDOs) for the three months ended March 31, 2019 and 2018, respectively (amounts in thousands):

Level 3 Liabilities:
 
Three Months Ended March 31,
 
2019
 
2018
Balance at beginning of period
$
11,022,248

 
$
9,189,459

Total losses (gains) (realized/unrealized)
 
 
 
Included in earnings (1)
237,789

 
(201,558
)
Purchases (2)
2,324,639

 

Paydowns
(37,481
)
 
(34,434
)
Balance at the end of period
$
13,547,195

 
$
8,953,467


(1) 
Amounts included in interest expense on Multi-Family CDOs and unrealized gain on multi-family loans and debt held in securitization trusts.
(2) 
During the three months ended March 31, 2019, the Company purchased PO securities and certain IOs and mezzanine CMBS securities issued from securitizations that it determined to consolidate and include in the Consolidated K-Series. As a result, the Company consolidated liabilities of these securitizations in the amount of $2.3 billion (see Notes 2 and 6)
Changes in Unrealized Gains (Losses) Included in Earnings for Level 3 Assets and Liabilities
The following table details the changes in unrealized gains (losses) included in earnings for the three months ended March 31, 2019 and 2018 for our Level 3 assets and liabilities held as of March 31, 2019 and 2018, respectively (dollar amounts in thousands):
 
Three Months Ended March 31,
 
 
2019
 
2018
 
Assets
 
 
 
 
Multi-family loans held in securitization trusts (1)
$
274,683

 
$
(172,546
)
 
Investments in unconsolidated entities (2)
3,661

 
1,038

 
Distressed and other residential mortgage loans at fair value (3)
9,337

 
(92
)
 
 
 
 
 
 
Liabilities
 
 
 
 
Multi-family debt held in securitization trusts (1)
(265,273
)
 
180,091

 


(1) 
Presented in unrealized gain on multi-family loans and debt held in securitization trusts, net on the Company's condensed consolidated statements of operations.
(2) 
Presented in other income on the Company's condensed consolidated statements of operations.
(3) 
Presented in net gain (loss) on distressed and other residential mortgage loans at fair value on the Company's condensed consolidated statements of operations.
Schedule of Assets Measured at Fair Value on a Non-recurring Basis

The following table presents assets measured at fair value on a non-recurring basis as of March 31, 2019 and December 31, 2018, respectively, on the Company's condensed consolidated balance sheets (dollar amounts in thousands):
 
Assets Measured at Fair Value on a Non-Recurring Basis at
 
March 31, 2019
 
December 31, 2018
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Residential mortgage loans held in securitization trusts – impaired loans, net
$

 
$

 
$
5,779

 
$
5,779

 
$

 
$

 
$
5,921

 
$
5,921

Schedule of Gains (Losses) Incurred for Assets Measured at Fair Value on a Non-recurring Basis

The following table presents gains (losses) incurred for assets measured at fair value on a non-recurring basis for the three months ended March 31, 2019 and 2018, respectively, on the Company’s condensed consolidated statements of operations (dollar amounts in thousands):
 
Three Months Ended March 31,
 
2019
 
2018
Residential mortgage loans held in securitization trusts – impaired loans, net
$
(38
)
 
$
110

Schedule of Carrying Value and Estimated Fair Value of Financial Instruments
The following table presents the carrying value and estimated fair value of the Company’s financial instruments at March 31, 2019 and December 31, 2018, respectively (dollar amounts in thousands):
 
 
 
March 31, 2019
 
December 31, 2018
 
Fair Value
Hierarchy Level
 
Carrying
Value
 
Estimated
Fair Value
 
Carrying
Value
 
Estimated
Fair Value
Financial Assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
Level 1
 
$
65,359

 
$
65,359

 
$
103,724

 
$
103,724

Investment securities available for sale
Level 2 or 3
 
1,583,965

 
1,583,965

 
1,512,252

 
1,512,252

Distressed and other residential mortgage loans, at fair value
Level 3
 
875,566

 
875,566

 
737,523

 
737,523

Distressed and other residential mortgage loans, net
Level 3
 
262,193

 
264,476

 
285,261

 
289,376

Investments in unconsolidated entities
Level 3
 
92,364

 
92,961

 
73,466

 
73,833

Preferred equity and mezzanine loan investments
Level 3
 
175,128

 
177,602

 
165,555

 
167,739

Multi-family loans held in securitization trusts
Level 3
 
14,328,336

 
14,328,336

 
11,679,847

 
11,679,847

Derivative assets
Level 2
 
14,873

 
14,873

 
10,263

 
10,263

Mortgage loans held for sale, net (1)
Level 3
 
2,960

 
3,134

 
3,414

 
3,584

Mortgage loans held for investment (1)
Level 3
 
1,580

 
1,580

 
1,580

 
1,580

Financial Liabilities:
 
 
 
 
 
 
 
 
 
Repurchase agreements
Level 2
 
2,273,005

 
2,273,005

 
2,131,505

 
2,131,505

Residential collateralized debt obligations
Level 3
 
49,247

 
47,004

 
53,040

 
50,031

Multi-family collateralized debt obligations
Level 3
 
13,547,195

 
13,547,195

 
11,022,248

 
11,022,248

Securitized debt
Level 3
 

 

 
42,335

 
45,030

Subordinated debentures
Level 3
 
45,000

 
45,011

 
45,000

 
44,897

Convertible notes
Level 2
 
131,301

 
136,693

 
130,762

 
135,689



(1) 
Included in receivables and other assets in the accompanying condensed consolidated balance sheets.